Agree, COVID has significant impact on many businesses and Terumo may not be exception in prioritising their investment.
similarly Animal health is not dead (contrary to what I believed before) but it is taking too long to get approval through European agency... IMO.
Ann: Improved Propofol TPM Formulation Passes Toxicology Study, page-138
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.338M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.2¢ | 0.2¢ | $240 | 120K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 50 | 43820232 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 43900696 | 24 |
View Market Depth
| Last trade - 10.00am 12/09/2024 (20 minute delay) ? |
| AVE (ASX) Chart |